Skip to content

Deep Relaxation Using Virtual Reality Intervention Before Surgery for Healthcare Professionals Working in the Operating Room

Deep Relaxation Using Virtual Reality Intervention Before Surgery for Healthcare Professionals Working in the Operating Room

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07470697
Acronym
DEEP_VR
Enrollment
80
Registered
2026-03-13
Start date
2026-06-01
Completion date
2026-07-01
Last updated
2026-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress, Stress and Burnout, Stress Biomarkers

Keywords

VR, Virtual Reality, Stress, Non-invasice biomarkers, Heart rate variabillity, Heart rate, Burnout, Resilience, hospital, operating room, healthcare professionals, doctor, operating room nurse, anesthesia nurse, surgeon, low stimulus environment

Brief summary

The goal of this clinical trials is to primary learn if deep relaxation using Virtual Reality (VR) compared to a low stimulus environment can lower perceived and measured stress in healthcare professionals working in the operating room. We aim to determine: * whether the use of a low-stimulus environment significantly lowers the stress response in OR health care workers just before entering the OR; * whether the use of a responsive VR system environment significantly lowers the stress response in OR health care workers just before entering the OR; * Whether the use of a responsive VR environment is both an effective and cost-effective solution compared to the low-stimulus environment, in terms of significantly mitigating stress in OR team members as measured by their biometrics, just before they enter the OR to do their job. Hypothesis * The use of a 10-minute real-time adaptive VR intervention or a low-stimulus environment intervention administered at least 15 minutes before entering the operating room (OR), significantly reduces stress in OR staff, as measured by a within-person reduction in heart rate of at least 10 beats per minute (BPM) over the 10-minute intervention period * The reduction in heart rate over a 10-minute intervention period is significantly greater for the real-time adaptive VR intervention compared to the low-stimulus environment intervention, with an expected mean difference (delta) of 5 BPM, indicating superior stress-reducing effects of the VR intervention. * The use of a real-time adaptive VR intervention and the use of a low stimulus environment intervention of 10 minutes at least 15 minutes before entering the OR significantly reduces perceived stress for OR staff, as measured by Numeric Rating Scale (NRS) stress scores within person.

Interventions

Participants will receive a VR headset, in which the participant can choose from a number of VR images and sceneries of the HealthyMind® (HM) VR simulation to relax. The software is able to adapt to user's HR and HRV, and developed by Partner HealthyMind (HM). HRV is chosen as prime parameter for biofeedback steering of scenery, as it is highly indicative and considered reliable in measuring a person's stress level. (27-30) Before starting the experience, participants select a VR scenery based on their personal preference. Allowing participants to choose their own VR scenery minimizes the risk of exposing them to an environment that could be stress-inducing rather than stress-reducing.(31, 32) HR and HRV will be measured in real time during the intervention using the POLAR OH1 armband built and registered for the purpose. We chose the POLAR OH1 band because of its accurate HRV measurements, its ability to connect with the VR device, and its user-friendliness. In respo

OTHERLow Stimulus Environment

Participants will be brought into an induced low-sensory, low-stimulus environment. This entails wearing the VR headset with a dark-only display, and no sound on headphones. This, to facilitate a calm environment without distractions. Before the start of the intervention, the VR headset will display a short visual and audio message confirming that the participant is in a low-stimulus environment and that the system is functioning properly.

Sponsors

Amsterdam UMC, location VUmc
Lead SponsorOTHER
Universitätsklinikum Hamburg-Eppendorf
CollaboratorOTHER
Rigshospitalet, Denmark
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Volunteering and consented healthcare professionals ( ≥ 18 years) working in the operating room * Circulatory-, scrub-, and anesthesia nurses, anesthesiologists, surgical specialists, residents, medical students, or persons in training for the above mentioned.

Exclusion criteria

* history of epilepsy. * claustrophobia or nyctophobia. * experienced VR scenery via a headset including headphones a trigger for headache, migraine, dizziness, drowsiness, nausea or other physical or mental discomfort. * vestibular nystagmus, otosclerosis, ear infections, * impaired hearing or deafness of either ear. * glaucoma, active eye infections or damage to orbital, cornea or lens. * diagnosed with chronic insomnia . * latex allergy as VR goggles may contain latex in the lens surround. * arrythmia, bradycardia or tachycardia, or those using cardiac medication against dysrhythmias. * All medication that may potentially induce dysrhythmias or of influence on blood pressure levels. * not able to wear a VR headset and/or noise canceling headphones for any other reason as indicated by themselves.

Design outcomes

Primary

MeasureTime frameDescription
Perceived Stress level- immediately before each intervention (pre-intervention) - immediately after each intervention (post-intervention)NRS score ranging from 0 (not stessed) to 10 (very stressed)
Non invasive biomarkersimmediately before each intervention (pre-intervention) for 5 minutes, during the intervention 10 minutes and immediately after each intervention 1 minute (post-intervention)Non invasive biomarkers eg heart rate and heart rate variability measured with a polarOH1 armband

Secondary

MeasureTime frameDescription
User satisfactionImmediately after completion of the last intervention of the study (post intervention after the third intervention)NRS score ranging from 0 (not satisfied) to 10 (very satisfied)
Cost-effectiveness analysis (CEA) of the intervention. up to 50 weeks after the last participant has completed all interventionsthrough study completion, an average of 1 yearCost-effectiveness will be assessed using a health economic evaluation framework. Direct and indirect costs of the intervention (e.g. staff time, training costs, materials, healthcare utilization) will be collected and compared against measured outcomes (e.g., reduction in stress/burnout and measured biomarkers)

Countries

Denmark, Germany

Contacts

CONTACTSophie Q Vermeulen, MD
s.q.vermeulen@amsterdamumc.nl0031639012875
PRINCIPAL_INVESTIGATORMarlies p Schijven, Prof. dr.

AmsterdamUMC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026